Publications by authors named "Koen Van Bockstal"
Article Synopsis
- * Out of 242 patients studied, only 29% showed "substantial benefit" from HeartLogic™, meaning the majority didn't see significant advantages from the monitoring system.
- * Key indicators for those who benefited included advanced HF symptoms, elevated NT-ProBNP levels, and other severe health markers, showing that sicker patients are more likely to gain from this type of remote monitoring.
Article Synopsis
- The HeartLogic algorithm for implantable cardiac defibrillators aims to detect early signs of fluid retention in heart failure patients and has been shown to be safe for clinical use.
- A study compared HeartLogic to standard telemonitoring in heart failure patients, focusing on worsening heart failure events, hospitalizations, and clinic visits.
- Results indicated that patients using HeartLogic experienced fewer worsening events, shorter hospital stays, and fewer visits for diuretic adjustments compared to those receiving standard care.
We describe the case of a young woman with a dual-chamber implantable cardioverter-defibrillator for long-QT syndrome who was referred to our emergency department (Cardiovascular Research Centre of Aalst, Belgium) because of an "arrhythmic storm" caused by atrial lead fracture. This case highlights the importance of the correct choice of both the device type and the pacing modality. ().
View Article and Find Full Text PDFBackground: Exercise capacity is an important aspect of quality of life in patients undergoing pacemaker implantation. Device algorithms for ventricular pacing avoidance have been developed to avoid unnecessary and potentially harmful effects of right ventricular pacing. However, little data exists on the immediate response of these algorithms to sudden AV block during exercise.
View Article and Find Full Text PDFAims: The implantable cardiac defibrillator/cardiac resynchronization therapy with defibrillator-based HeartLogic™ algorithm has recently been developed for early detection of impending decompensation in heart failure (HF) patients; but whether this novel algorithm can reduce HF hospitalizations has not been evaluated. We investigated if activation of the HeartLogic algorithm reduces the number of hospital admissions for decompensated HF in a 1 year post-activation period as compared with a 1 year pre-activation period.
Methods And Results: Heart failure patients with an implantable cardiac defibrillator/cardiac resynchronization therapy with defibrillator with the ability to activate HeartLogic and willingness to have remote device monitoring were included in this multicentre non-blinded single-arm trial with historical comparison.